1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults

Technology appraisal guidance [TA170] Published date: 22 April 2009

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Overview
  • 1 Guidance
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Related NICE guidance
  • 8 Review of guidance
  • Appendix A: Appraisal Committee members, guideline representatives and NICE project team
  • Appendix B: Sources of evidence considered by the Committee
  • Changes after publication
  • About this guidance
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...
  • Download

Guidance

  • Next

7 Related NICE guidance

7 Related NICE guidance

  • Dabigatran etexilate for the prevention of venous thromboembolim after hip or knee replacement surgery in adults. NICE technology appraisal guidance 157 (2008).

  • Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery. NICE clinical guideline 46 (2007). [Replaced by NICE clinical guideline 92]

  • National Institute for Health and Care Excellence (NICE)

  • Next